NYCOMED SALUTAR,
Similar Organizations
Avantome
Avantome is a Biotechnology company.
More informations about "Nycomed Salutar,"
Nycomed Salutar, - Crunchbase Company Profile & Funding
Alternatives and possible competitors to Nycomed Salutar, may include Lunacell, Avantome, and Icoria. Nycomed Salutar, is a Biotechnology company.See details»
Nycomed Salutar, Inc.: Drug pipelines, Patents, Clinical trials
Jul 20, 2023 · Explore Nycomed Salutar, Inc. with its drug pipeline, therapeutic area, technology platform, 3 literature.See details»
Nycomed - Wikipedia
Nycomed is a Swiss pharmaceutical company. Nycomed was acquired by Takeda Pharmaceuticals in September 2011. Production was located in Norway, Denmark, Poland, Austria, Belgium, Germany, Estonia, India, Mexico, Brazil and Argentina. Head office is located in Zürich, Switzerland. Total revenue was €3,400 million in 2006 and the group had 12,000 employees then. The company awarded an annual prize totaling 20,000 euros to four excellent junior scientists at the University of KonstanzSee details»
Nycomed Company Profile 2024: Valuation, Investors, …
Manufacturer of pharmaceutical and OTC drugs catering to Europe and emerging markets. The company offers a diversified product portfolio for the treatment …See details»
About – Scott Rocklage Blog
Rocklage has served as Chairman and CEO of Cubist Pharmaceuticals, President and CEO of Nycomed Salutar, and has also held various R&D positions at Salutar and Catalytica. Dr. …See details»
Scott M. Rocklage - Founding Partner @ 5AM Ventures
Rocklage has served as Chairman and CEO of Cubist Pharmaceuticals, President and CEO of Nycomed Salutar, President, CEO and Chairman of Nycomed Interventional and has also held …See details»
Board of Directors - Pulmatrix
Rocklage was previously chairman and chief executive officer of Cubist Pharmaceuticals Inc., president and chief executive officer of Nycomed Salutar and Nycomed Interventional, and …See details»
Nycomed - PharmaNews.eu
Mar 2, 2011 · Nycomed is a Takeda company since end of September 2011. Takeda is a research-based global company with its main focus on pharmaceuticals. The combined …See details»
Nycomed Company Profile - Office Locations, Competitors ... - Craft
Nycomed is a pharmaceutical company that focuses on producing medicines. It offers medicines for gastroenterology, respiratory, inflammatory disease, pain, osteoporosis, and tissue …See details»
Nycomed’s novel COPD therapy roflumilast receives FDA approval
Nycomed’s US partner Forest Laboratories, Inc.announced that DalirespTM (roflumilast) was approved by the US Food and Drug Administration (FDA) as a treatment to reduce the risk of …See details»
Scott M. Rocklage - Founding Partner at 5AM Ventures - The Org
New Drug Applications (Omniscanâ„¢, Teslascan® and Cubicin®). He has served as Chairman and CEO of Cubist Pharmaceuticals, President and CEO of Nycomed Salutar and has also …See details»
NYCOMED TO PAY $ 55 MIL. FOR CONTRAST IMAGING FIRM …
NYCOMED TO PAY $ 55 MIL. FOR CONTRAST IMAGING FIRM SALUTAR under an option agreement announced by the two firms in October. A merger with Salutar, Nycomed noted,See details»
Scott M. Rocklage - Chairman at Expansion Therapeutics - The Org
Rocklage has served as Chairman and CEO of Cubist Pharmaceuticals, President and CEO of Nycomed Salutar, and has also held various R&D positions at Salutar and Catalytica. Dr. …See details»
Scott M. Rocklage – Cubist Pharmaceuticals (cbst) - The Wall …
Dec 14, 1998 · From 1990 to 1994, Dr. Rocklage served as President and Chief Executive Officer of Nycomed Salutar, Inc., a diagnostic imaging company and from 1992 to 1994, he also …See details»
Scott Rocklage | PhD - Nouscom
Scott has served as Chairman and CEO of Cubist Pharmaceuticals (acquired by Merck), President and CEO of Nycomed Salutar, and has also held various R&D positions at Salutar …See details»
Adducts of macrocyclic chelants - Nycomed Salutar, Inc.
Dec 30, 1993 · There are provided polychelants and their metal chelates which are useful in diagnostic imaging and in radiotherapy and which comprise a plurality of macrocyclic chelant …See details»
Scott M. Rocklage – Cubist Pharmaceuticals Inc (cbst)
Dec 2, 1999 · From 1990 to 1994, Dr. Rocklage served as President and Chief Executive Officer of Nycomed Salutar, Inc., a diagnostic imaging company and from 1992 to 1994, he also …See details»
MRI contrast agents from Nycomed Salutar - bioworld.com
Apr 25, 2023 · Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, business, financing, …See details»
Nycomed Salutar - Writerguy Portfolio
Lauren brilliantly juxtaposed lush black-and-white photos with the vibrant medical imaging, and the brochure went on to win design awards. Meanwhile, the copywriter was hammering out a …See details»
Rocklage, Scott M. - The Wall Street Transcript
Oct 12, 2001 · From 1990 to 1994, Dr. Rocklage served as President and Chief Executive Officer of Nycomed Salutar, Inc., a diagnostic imaging company and from 1992 to 1994, he also …See details»